Mutual Fund Ownership
Ownership as on: Tue, 27 Feb, 2024

WhiteOak Capital Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)4.92
% of AUM5.78%

ITI Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)7.18
% of AUM4.74%

SBI Healthcare Opportunities Fund Regular Growth

NA
Equity
Amount Invested (Cr.)112.00
% of AUM4.61%

Invesco India Focused Fund Regular Growth

3/5
Equity
Amount Invested (Cr.)86.70
% of AUM4.09%

Motilal Oswal ELSS Tax Saver Fund Regular Plan Growth

4/5
Equity
Amount Invested (Cr.)106.00
% of AUM3.50%

FAQs about Mankind Pharma share price

Mankind Pharma is trading at 2100.00 as on Tue Feb 27 2024 09:59:39. This is 1.70% upper as compared to its previous closing price of 2064.85.

The market capitalization of Mankind Pharma is 84123.57 Cr as on Tue Feb 27 2024 09:59:39.

The average broker rating on Mankind Pharma is Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 5 analysts have given a buy rating
  • 4 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Mankind Pharma is 2297.00 whereas the 52 wk low is 1240.75

Mankind Pharma can be analyzed on the following key metrics -

  • TTM P/E: -
  • Sector P/E: 26.69
  • Dividend Yield: -%
  • D/E ratio: -

Mankind Pharma reported a net profit of 1281.86 Cr in 2023.

Recommended For You
Images
Trending Stocks
962.75+26.05(2.78%)
1,492.90+26.15(1.78%)
6,555.15-85.95 (-1.29%)